Dermata Therapeutics (DRMA) Cash from Operations (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Cash from Operations of 2479718.0 for Q1 2026, down 28.21% year-over-year from 3454256.64 in Q1 2025, and down 77.12% quarter-over-quarter from 1400000.0 in Q4 2025.
Dermata Therapeutics (DRMA) Cash from Operations (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Cash from Operations history runs 7 years deep, the most recent figure standing at 2479718.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 28.21% year-over-year to 2479718.0; the TTM figure through Mar 2026 stood at 8345652.0 (up 19.7% YoY), while the FY2025 annual figure was 7800000.0, up 30.13% from the prior year.
- Cash from Operations for Q1 2026 stood at 2479718.0, down from 1400000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1147305.0 in Q4 2023, with the low at 3418927.0 in Q3 2024.
- The 5-year median for Cash from Operations is 1934066.0 (2025), against an average of 2157985.94.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 235.97% in 2022, then jumped 51.95% in 2025.
- Dermata Therapeutics' Cash from Operations stood at 1825528.0 in 2022, then soared by 37.15% to 1147305.0 in 2023, then tumbled by 153.95% to 2913614.0 in 2024, then surged by 51.95% to 1400000.0 in 2025, then tumbled by 77.12% to 2479718.0 in 2026.
- Business Quant data shows DRMA's Cash from Operations at 2479718.0 in Q1 2026, 1400000.0 in Q4 2025, and 1800000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Dermata Therapeutics | 5.40 Mn | 5.40 Mn | - | -2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.48 Mn |
| Mar 31, 2026 | -2.48 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | -2.67 Mn |
| Jun 30, 2025 | -2.67 Mn |
| Mar 31, 2025 | -1.93 Mn |
| Mar 31, 2025 | -1.93 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | -3.42 Mn |
| Sep 30, 2024 | -3.42 Mn |
| Jun 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -2.13 Mn |
| Mar 31, 2024 | -2.70 Mn |
| Mar 31, 2024 | -2.70 Mn |
| Dec 31, 2023 | -1.15 Mn |
| Dec 31, 2023 | -1.15 Mn |